AIDS
AIDS The term “AIDS” is the abbreviation for Acquired Immune Deficiency Syndrome. AIDS was first identified in 1984 and a vaccine was predicted to be available within two years. ... AIDS causes a person’s cells to be permanently infected as well as infecting their offspring. ... The body’s immune system tries to fight against the AIDS disease with antibodies and cytotoxic T cells that battle against billions of virus particles hatched from infected cells every day. AIDS is a terminally ill disease, which is passed sexually, through blood, and through offspring, and as the body’s immune system fights against the disease, there is no survival and no cure as of the present. Several vaccines have been tested throughout the years on various people who have been infected with the AIDS disease. ... Lastly, the potential vaccine is given to thousands of AIDS infected patients. ... There are mainly five different areas of the world that are heavily affected by AIDS. North America and Europe have many cases of AIDS, but the most cases are found in Sub-Sahara Africa. Testing is being made on many AIDS infected individuals. ... She is one of many who have AIDS in Africa and face the danger of being murdered by other Africans who fear the spread of the disease. ... Mother-to-child transmission is one of the driving forces behind AIDS in South Africa and nine out of ten children in the world who are infected with AIDS live in Sub-Sahara Africa. ... The antiretroviral drug, AZT, is created to prevent infected mothers from passing the AIDS virus to their infants in the womb or at birth. Prices for AIDS drugs are costly, but are hoped to lower in price by 80% in Africa due to the poverty. Five global pharmaceutical companies met with the World Health Organization (WHO) in the latest of a series of talks to discuss making their AIDS drugs more affordable for poorer nations. ... Former President, Bill Clinton, signed an executive order saying that the United States government would not interfere if African nations flouted patents held by United States pharmaceutical companies by importing generic AIDS drugs made in such countries.